Department of Clinical Biochemistry, University of Copenhagen, Copenhagen, Denmark.
Adv Clin Chem. 2012;58:45-8. doi: 10.1016/b978-0-12-394383-5.00009-6.
Plasma measurement of natriuretic peptides is a "must" for clinical laboratories. For the next generation measurement, the unraveling of the molecular complexity of the peptides points toward a more qualitative assessment, as the posttranslational processing also changes with disease. Changes in the molecular heterogeneity could in itself contain valuable information of clinical status, and the time seems right for industry and dedicated researchers in the field to get together and discuss the next generation natriuretic peptide measurement. In such an environment, new strategies can be developed with the mutual aim of making already very good plasma markers even better.
血浆中利钠肽的测量对临床实验室来说是“必备”的。对于下一代的测量方法,肽的分子复杂性的揭示指向更定性的评估,因为肽的翻译后加工也会随疾病而改变。分子异质性的改变本身可能包含有价值的临床状态信息,现在正是行业和该领域的专业研究人员聚集在一起讨论下一代利钠肽测量方法的时候了。在这样的环境下,可以制定新的策略,共同的目标是使已经非常好的血浆标志物变得更好。